Acquisition Finalized

Marico Limited has successfully acquired a 75% stake in Vietnam-based Skinetiq Joint Stock Company, completing the transaction on April 2, 2026. This deal, initially announced on February 9, 2026, makes Skinetiq a subsidiary of Marico's wholly owned unit, Marico South East Asia Corporation. Through this acquisition, Marico gains Skinetiq's digital-first skincare brand 'Candid' and exclusive rights to distribute the 'Murad' brand in Vietnam, marking a strategic entry into the country's premium beauty market.

Strategic Growth in Vietnam

This acquisition is a significant step for Marico to deepen its presence in the fast-growing Southeast Asian beauty market. Vietnam, noted for its strong economic fundamentals and evolving beauty preferences, is a key focus area for the company. The move bolsters Marico's direct-to-consumer (D2C) approach and expands its premium product offerings in an important international region.

Marico's Acquisition Strategy

Marico, a prominent Indian consumer goods company, has been strategically acquiring businesses to enhance its premium and digital offerings. This Vietnam acquisition mirrors Marico's 'string of pearls' strategy, which targets smaller, high-potential, founder-led brands. Previously, Marico invested in Indian digital-first brands such as Cosmix Wellness and 4700BC, diversifying into faster-growing, high-margin sectors. Vietnam's beauty sector is rapidly evolving, with e-commerce and social commerce channels playing a major role in consumer purchasing, which aligns perfectly with Skinetiq's digital-first model and Marico's international D2C strategy.

Integration and Future Plans

Skinetiq Joint Stock Company now operates as a subsidiary of Marico Limited, with its brands and distribution networks being integrated into Marico's global operations. The company is expected to use Skinetiq's existing digital infrastructure and market reach to grow 'Candid' and 'Murad' brands in Vietnam. This acquisition also creates a platform for Marico to launch additional brands in the Vietnamese market.

Key Risks to Monitor

Key risks for investors to watch include the successful integration of Skinetiq into Marico's operations and the competitive nature of Vietnam's skincare market. Marico must effectively navigate local market conditions and consumer tastes to maximize this investment. Additionally, potential future payments tied to performance milestones introduce execution risk.

Industry Trends and Peers

Marico's move is in line with industry trends as major consumer goods companies increasingly seek growth outside traditional channels by expanding into premium and digital-first segments. Competitors such as Hindustan Unilever, Dabur, and global giants like L'Oréal are also actively developing their premium beauty lines and direct-to-consumer capabilities. Marico's focused strategy on a market like Vietnam with a digital-first approach sets it apart.

Recent Financial Performance

Marico recently reported its financial results for the third quarter of fiscal year 2026 (Q3 FY26). The company posted consolidated revenue of ₹3,537 crore, marking a 27% increase year-on-year. Consolidated net profit reached ₹447 crore, up 12% from the previous year. EBITDA for the quarter was ₹592 crore, an 11% rise year-on-year, with EBITDA margins reported at 16.7%.

Investor Focus Ahead

Investors will be closely watching the performance of the 'Candid' and 'Murad' brands under Marico's leadership and how rapidly the company can scale them in Vietnam. The speed of integration and Marico's success in utilizing Skinetiq's digital strengths will be key indicators. Future announcements about further Southeast Asian expansion or new acquisitions in premium beauty and D2C sectors will also be significant for tracking Marico's strategy.